Cargando…
New drug candidates for treatment of atypical meningiomas: An integrated approach using gene expression signatures for drug repurposing
BACKGROUND: Atypical meningiomas are common central nervous system neoplasms with high recurrence rate and poorer prognosis compared to their grade I counterparts. Surgical excision and radiotherapy remains the mainstay therapy but medical treatments are limited. We explore new drug candidates using...
Autores principales: | Zador, Zsolt, King, Andrew T., Geifman, Nophar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5860760/ https://www.ncbi.nlm.nih.gov/pubmed/29558515 http://dx.doi.org/10.1371/journal.pone.0194701 |
Ejemplares similares
-
Multimorbidity states associated with higher mortality rates in organ dysfunction and sepsis: a data-driven analysis in critical care
por: Zador, Zsolt, et al.
Publicado: (2019) -
Gene Expression Signatures Identify Biologically Homogenous Subgroups of Grade 2 Meningiomas
por: Zador, Zsolt, et al.
Publicado: (2020) -
Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approach
por: O’Donovan, Sinead M., et al.
Publicado: (2021) -
Drug repurposing for COVID-19: Approaches, challenges and promising candidates
por: Ng, Yan Ling, et al.
Publicado: (2021) -
Repurposable Drugs for Immunotherapy and Strategies to Find Candidate Drugs
por: Sakai, Norihiro, et al.
Publicado: (2023)